Distinct Subdomains of Human TAFII130 Are Required for Interactions with Glutamine-Rich Transcriptional Activators
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
TFIID is a multiprotein complex consisting of the TATA box binding protein and multiple tightly associated proteins (TAFIIs) that are required for transcription by selected activators. We previously reported cloning and partial characterization of human TAFII130 (hTAFII130). The central domain of hTAFII130 contains four glutamine-rich regions, designated Q1 to Q4, that are involved in interactions with the transcriptional activator Sp1. Mutational analysis has revealed specific regions within the glutamine-rich (Q1 to Q4) central region of hTAFII130 that are required for interaction with distinct activation domains. We tested amino- and carboxyl-terminal deletions of hTAFII130 for interaction with Sp1 activation domains A and B (Sp1A and Sp1B) and the N-terminal activation domain of CREB (CREB-N) by using the yeast two-hybrid system. Our results indicate that Sp1B interacts almost exclusively with the Q1 region of hTAFII130. In contrast, Sp1A makes multiple contacts with Q1 to Q4 of hTAFII130, while CREB-N interacts primarily with the Q1-Q2 hTAFII130 subdomain. Consistent with these interaction studies, overexpression of the Q1-to-Q4 region in HeLa cells inhibits Sp1- but not VP16-mediated transcriptional activation. These findings indicate that the Q1-to-Q4 region of hTAFII130 is required for Sp1-mediated transcriptional enhancement in mammalian cells and that different activation domains target distinct subdomains of hTAFII130.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transcriptional activation by recruitment
Ptashne, M., & Gann, A. (1997) · Nature · doi:10.1038/386569a0 · Cited by 1,158 · cited 2×
“hTAFII130 (1-947), wild-type hTAFII130 carrying amino acids 1 to 947.”
BackgroundMethodThe enhanceosome and transcriptional synergy.
Carey, M. (1998) · Cell · doi:10.1016/s0092-8674(00)80893-4 · Cited by 553 · cited 1×
“hTAFII130 (1-947), wild-type hTAFII130 carrying amino acids 1 to 947.”
MethodMerika, M., Williams, A. J., Chen, G., Collins, T., & Thanos, D. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80028-3 · Cited by 435
Cited by
Transcriptional regulation by the phosphorylation-dependent factor CREB
Mayr, B., & Montminy, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085068 · Cited by 2,587
“cgi?l=6874">TAF II 130 , a component of the TFIID comple”
BackgroundCREB and the CRTC co-activators: sensors for hormonal and metabolic signals
Altarejos, J. Y., & Montminy, M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3072 · Cited by 1,040
Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006) · Cell · doi:10.1016/j.cell.2006.09.015 · Cited by 1,012
Self-citationSp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease
Dunah, A. W., Jeong, H., Griffin, A., Kim, Y.-M., Standaert, D. G., Hersch, S. M., Mouradian, M. M., Young, A. B., Tanese, N., & Krainc, D. (2002) · Science · doi:10.1126/science.1072613 · Cited by 708
Self-citationConkright, M. D., Canettieri, G., Screaton, R., Guzman, E., Miraglia, L., Hogenesch, J. B., & Montminy, M. (2003) · Molecular Cell · doi:10.1016/j.molcel.2003.08.013 · Cited by 602
Sp1 and the ‘hallmarks of cancer’
Beishline, K., & Azizkhan‐Clifford, J. (2015) · The FEBS Journal · doi:10.1111/febs.13148 · Cited by 524
Sp transcription factor family and its role in cancer
Safe, S., & Abdelrahim, M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.006 · Cited by 500
Wang, D.-Z., Li, S., Hockemeyer, D., Sutherland, L., Wang, Z., Schratt, G., Richardson, J. A., Nordheim, A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222561499 · Cited by 474
Gene regulation by Sp1 and Sp3
Li, L., He, S., Sun, J.-M., & Davie, J. R. (2004) · Biochemistry and Cell Biology · doi:10.1139/o04-045 · Cited by 418
Pardali, K., Kurisaki, A., Morén, A., ten Dijke, P., Kardassis, D., & Moustakas, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909467199 · Cited by 392
Sp1: Emerging roles—Beyond constitutive activation of TATA-less housekeeping genes
Wierstra, I. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.074 · Cited by 336
TAFs revisited: more data reveal new twists and confirm old ideas
Albright, S. R., & Tjian, R. (2000) · Gene · doi:10.1016/s0378-1119(99)00495-3 · Cited by 319
Wyttenbach, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.17.1829 · Cited by 272
Brightbill, H. D., Plevy, S. E., Modlin, R. L., & Smale, S. T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1940 · Cited by 268
Poncelet, A.-C., & Schnaper, H. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006442200 · Cited by 227
Kardassis, D., Papakosta, P., Pardali, K., & Moustakas, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29572 · Cited by 185
Abnormal Sp1 transcription factor expression in Alzheimer disease and tauopathies
Santpere, G., Nieto, M., Puig, B., & Ferrer, I. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.062 · Cited by 70
Isomura, H., Stinski, M. F., Kudoh, A., Daikoku, T., Shirata, N., & Tsurumi, T. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9597-9607.2005 · Cited by 66
“tion of the TATA box by the TATA-binding protein and TATA-binding protein-associated factors (TAFs) is essential for minimal promoter activity, Sp1 may interact with TAF4 (57) for synergistic effects on transcription from the HCMV MIE promoter (11).”
BackgroundShea, C., Richer, J., Tzertzinis, G., & Maina, C. V. (2010) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2010.02.002 · Cited by 21
Metadata
- Authors
- Saluja, D., Vassallo, M. F., & Tanese, N.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1998-10-01
- Volume
- 18
- Issue
- 10
- Pages
- 5734-5743
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W1795977892
- Cited by
- 133
- References
- 3
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.